<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/67650066209</prism:url><dc:identifier>SCOPUS_ID:67650066209</dc:identifier><eid>2-s2.0-67650066209</eid><prism:doi>10.1186/1475-2859-8-27</prism:doi><article-number>27</article-number><dc:title>Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>17</citedby-count><prism:publicationName>Microbial Cell Factories</prism:publicationName><source-id>18593</source-id><prism:issn>14752859</prism:issn><prism:volume>8</prism:volume><prism:coverDate>2009-05-22</prism:coverDate><dc:creator><author auid="26639199800" seq="1"><ce:initials>D.S.</ce:initials><ce:indexed-name>Cunningham D.S.</ce:indexed-name><ce:surname>Cunningham</ce:surname><ce:given-name>Drew S.</ce:given-name><preferred-name> <ce:initials>D.S.</ce:initials> <ce:indexed-name>Cunningham D.</ce:indexed-name> <ce:surname>Cunningham</ce:surname> <ce:given-name>Drew S.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26639199800</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"><ce:para>Background: Plasmids are being reconsidered as viable vector alternatives to viruses for gene therapies and vaccines because they are safer, non-toxic, and simpler to produce. Accordingly, there has been renewed interest in the production of plasmid DNA itself as the therapeutic end-product of a bioprocess. Improvement to the best current yields and productivities of such emerging processes would help ensure economic feasibility on the industrial scale. Our goal, therefore, was to develop a stoichiometric model of Escherichia coli metabolism in order to (1) determine its maximum theoretical plasmid-producing capacity, and to (2) identify factors that significantly impact plasmid production. Results: Such a model was developed for the production of a high copy plasmid under conditions of batch aerobic growth on glucose minimal medium. The objective of the model was to maximize plasmid production. By employing certain constraints and examining the resulting flux distributions, several factors were determined that significantly impact plasmid yield. Acetate production and constitutive expression of the plasmid's antibiotic resistance marker exert negative effects, while low pyruvate kinase (Pyk) flux and the generation of NADPH by transhydrogenase activity offer positive effects. The highest theoretical yield (592 mg/g) resulted under conditions of no marker or acetate production, nil Pyk flux, and the maximum allowable transhydrogenase activity. For comparison, when these four fluxes were constrained to wild-type values, yields on the order of tens of mg/g resulted, which are on par with the best experimental yields reported to date. Conclusion: These results suggest that specific plasmid yields can theoretically reach 12 times their current experimental maximum (51 mg/ g). Moreover, they imply that abolishing Pyk activity and/or transhydrogenase up-regulation would be useful strategies to implement when designing host strains for plasmid production; mutations that reduce acetate production would also be advantageous. The results further suggest that using some other means for plasmid selection than antibiotic resistance, or at least weakening the marker's expression, would be beneficial because it would allow more precursor metabolites, energy, and reducing power to be put toward plasmid production. Thus far, the impact of eliminating Pyk activity has been explored experimentally, with significantly higher plasmid yields resulting. Â© 2009 Cunningham et al; licensee BioMed Central Ltd.</ce:para></abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/67650066209" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=67650066209&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-67650066209%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60015543" id="60015543"><affilname>University of Pittsburgh</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author auid="26639199800" seq="1"><ce:initials>D.S.</ce:initials><ce:indexed-name>Cunningham D.S.</ce:indexed-name><ce:surname>Cunningham</ce:surname><ce:given-name>Drew S.</ce:given-name><preferred-name> <ce:initials>D.S.</ce:initials> <ce:indexed-name>Cunningham D.</ce:indexed-name> <ce:surname>Cunningham</ce:surname> <ce:given-name>Drew S.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26639199800</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author><author auid="7004206154" seq="2"><ce:initials>R.R.</ce:initials><ce:indexed-name>Koepsel R.R.</ce:indexed-name><ce:surname>Koepsel</ce:surname><ce:given-name>Richard R.</ce:given-name><preferred-name> <ce:initials>R.R.</ce:initials> <ce:indexed-name>Koepsel R.</ce:indexed-name> <ce:surname>Koepsel</ce:surname> <ce:given-name>Richard R.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7004206154</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60015543" id="60015543"/></author><author auid="7003267210" seq="3"><ce:initials>M.M.</ce:initials><ce:indexed-name>Ataai M.M.</ce:indexed-name><ce:surname>Ataai</ce:surname><ce:given-name>Mohammad M.</ce:given-name><preferred-name> <ce:initials>M.M.</ce:initials> <ce:indexed-name>Ataai M.</ce:indexed-name> <ce:surname>Ataai</ce:surname> <ce:given-name>Mohammad M.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7003267210</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60015543" id="60015543"/></author><author auid="7003978111" seq="4"><ce:initials>M.M.</ce:initials><ce:indexed-name>Domach M.M.</ce:indexed-name><ce:surname>Domach</ce:surname><ce:given-name>Michael M.</ce:given-name><preferred-name> <ce:initials>M.M.</ce:initials> <ce:indexed-name>Domach M.</ce:indexed-name> <ce:surname>Domach</ce:surname> <ce:given-name>Michael M.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7003978111</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></authors></abstracts-retrieval-response>
